1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Patients with suggested recurrence of paraganglioma (surgically treated paragangliomas)
PatientLocalizationInterval Between Surgery and MRIMaximal Dimension (mm)Probability of PGFinal Diagnosis (reference standard)
C MRICE-MRA
1Vagal4 years2012PG (surgery + pathology)
2Jugulotympanic9 months1612PG (SD)
3Vagal4 years2222PG (SD)
4Jugulotympanic6 months4122PG (SD)
CBT6 months410Postoperative scar (follow-up)
  • Note:—CBT indicates carotid body tumor; C MRI, conventional MR imaging; PG, paraganglioma; SD, surgical data (known tumor residue); 2, probable; 1, uncertain; 0, improbable.